Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Uncomplicated Falciparum Malaria in Western Kenya
Phase of Trial: Phase III
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Artesunate/pyronaridine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 24 Nov 2017 Status changed from recruiting to completed.
- 13 Apr 2017 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 13 Apr 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.